Roth Capital Starts Fate Therapeutics (FATE) at Buy
Tweet
Share
E-mailGet Alerts FATE Hot Sheet
Price: $3.13 +6.83%
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 36
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 36
Join SI Premium – FREE
Roth Capital initiated coverage on Fate Therapeutics (NASDAQ: FATE) with a Buy rating and a price target of $8.00.
For an analyst ratings summary and ratings history on Fate Therapeutics click here. For more ratings news on Fate Therapeutics click here.
Shares of Fate Therapeutics closed at $3.18 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roth/MKM Starts OS Therapies, Inc (OSTX) at Buy, PT $7, 'Durable Survival Supports OST-HER2 Approval'
- B.Riley Starts Zip Co Ltd (Z1P:AU) (ZIZTF) at Buy
- Huntington Starts The York Water Company (YORW) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
